Prediction of in vivo drug clearance from in vitro data. II: Potential inter-ethnic differences

References

• Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. Blackwell, Oxford 2001
   Google Scholar
• Bjornsson TD, Wagner JA, Donahue SR, Harper D, Karim A, Khouri MS, Murphy WR, Roman K, Schneck D, Sonnichsen DS, et al. A review and assessment of potential sources of ethnic differences in drug responsiveness. Journal of Clinical Pharmacology 2003; 43: 943–967
   PubMed Web of Science ®Google Scholar
• Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight are known. Archives of Internal Medicine 1916; 17: 863–871
   Google Scholar
• Elmed Eisai Company Ltd. Triazolam tablets (Japanese). Prescribing Information. Elmed Eisai Company Ltd, Tokyo 2003
   Google Scholar
• Fujisawa Pharmaceutical Company Ltd. Myslee tablets (Japanese). Prescribing Information. Fujisawa Pharmaceutical Company Ltd, Tokyo 2003
   Google Scholar
• Furukori H, Otani K, Yasui N, Kondo T, Kaneko S, Shimoyama R, Ohkubo T, Nagasaki T, Sugawara K. Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam. Neuropsychopharmacology 1998; 18: 364–369
   PubMed Web of Science ®Google Scholar
• Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: A height–weight formula validated in infants, children, and adults. Journal of Pediatrics 1978; 93: 62–66
   PubMed Web of Science ®Google Scholar
• Health and Nutrition Information Infrastructure Database, National Institute of Health and Nutrition. Japanese Ministry of Health, Labour and Welfare, Tokyo 1995, (available at: http://nihn-jst.nih.go.jp:8888/nns/owa/nns_main.hm01) (accessed on November 2003). 2005
   Google Scholar
• Heinemann A, Wischhusen F, Puschel K, Rogiers X. Standard liver volume in the Caucasian population. Liver Transplantation and Surgery 1999; 5: 366–368
   PubMedGoogle Scholar
• Hiratsuka M, Takekuma Y, Endo N, Narahara K, Hamdy SI, Kishikawa Y, Matsuura M, Agatsuma Y, Inoue T, Mizugaki M. Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population. European Journal of Clinical Pharmacology 2002; 58: 417–421
   PubMed Web of Science ®Google Scholar
• Horai Y, Nakano M, Ishizaki T, Ishikawa K, Zhou HH, Zhou BI, Liao CL, Zhang LM. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese. Clinical Pharmacology and Therapeutics 1989; 46: 198–207
   PubMed Web of Science ®Google Scholar
• Howgate EM, Rowland-Yeo K, Proctor NJ, Tucker GT, Rostami-Hodjegan A. Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability. Xenobiotica 2006; 36: 473–497
   PubMed Web of Science ®Google Scholar
• Ieiri I, Kubota T, Urae A, Kimura M, Wada Y, Mamiya K, Yoshioka S, Irie S, Amamoto T, Nakamura K, et al. Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects. Clinical Pharmacology and Therapeutics 1996; 59: 647–653
   PubMed Web of Science ®Google Scholar
• Ikegami H. The effect of aging on pharmacokinetics and pharmacodynamics of tolbutamide. Nippon Ronen Igakkai Zasshi 1985; 22: 218–223, [in Japanese]
   PubMedGoogle Scholar
• Imaoka S, Yamada T, Hiroi T, Hayashi K, Sakaki T, Yabusaki Y, Funae Y. Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochemical Pharmacology 1996; 51: 1041–1050
   PubMed Web of Science ®Google Scholar
• Ishizaki T, Eichelbaum M, Horai Y, Hashimoto K, Chiba K, Dengler HJ. Evidence for polymorphic oxidation of sparteine in Japanese subjects. British Journal of Clinical Pharmacology 1987; 23: 482–485
   PubMed Web of Science ®Google Scholar
• Jinno H, Tanaka-Kagawa T, Ohno A, Makino Y, Matsushima E, Hanioka N, Ando M. Functional characterization of cytochrome P450 2B6 allelic variants. Drug Metabolism and Disposition 2003; 31: 398–403
   PubMed Web of Science ®Google Scholar
• Johansson I, Lundqvist E, Bertilsson L, Dahl ML, Sjoqvist F, Ingelman-Sundberg M. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proceedings of the National Academy of Sciences. USA 1993; 90: 11825–11829
   PubMed Web of Science ®Google Scholar
• Johnson TN, Sabzghabaee A, Rostami-Hodjegan A, Tucker GT. Prediction of age related changes in midazolam clearance in children. British Journal of Clinical Pharmacology 2003; 55: 432–433
   Web of Science ®Google Scholar
• Johnson TN, Tucker GT, Tanner MS, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: A meta analysis. Liver Transplantation 2005; 12: 1481–1493
   Web of Science ®Google Scholar
• Jurima M, Inaba T, Kadar D, Kalow W. Genetic polymorphism of mephenytoin p(4′)-hydroxylation: Difference between Orientals and Caucasians. British Journal of Clinical Pharmacology 1985; 19: 483–487
   PubMed Web of Science ®Google Scholar
• Kim K, Johnson JA, Derendorf H. Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms. Journal of Clinical Pharmacology 2004; 44: 1083–1105
   PubMed Web of Science ®Google Scholar
• Kim RB, Yamazaki H, Chiba K, O'Shea D, Mimura M, Guengerich FP, Ishizaki T, Shimada T, Wilkinson GR. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. Journal of Pharmacology and Experimental Therapeutics 1996; 279: 4–11
   PubMed Web of Science ®Google Scholar
• Kyowa Pharmaceutical Industry Company Ltd. Halrack tablets (Japanese). Prescribing Information. Kyowa Pharmaceutical Industry Company Ltd. 2003
   Google Scholar
• Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U, Eichelbaum M, Schwab M, Zanger UM. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 2001; 11: 399–415
   PubMedGoogle Scholar
• Mitsunaga Y, Kubota T, Ishiguro A, Yamada Y, Sasaki H, Chiba K, Iga T. Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population. Mutation Research 2002; 505: 83–85
   PubMed Web of Science ®Google Scholar
• Muck W, Tanaka T, Ahr G, Kuhlmann J. No interethnic differences in stereoselective disposition of oral nimodipine between Caucasian and Japanese subjects. International Journal of Clinical Pharmacology and Therapeutics 1996; 34: 163–171
   PubMed Web of Science ®Google Scholar
• Muck W, Unger S, Kawano K, Ahr G. Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. British Journal of Clinical Pharmacology 1998; 45: 583–590
   PubMed Web of Science ®Google Scholar
• Nakamura K, Goto F, Ray WA, McAllister CB, Jacqz E, Wilkinson GR, Branch RA. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clinical Pharmacology and Therapeutics 1985; 38: 402–408
   PubMed Web of Science ®Google Scholar
• Nakasa H, Komiya M, Ohmori S, Rikihisa T, Kiuchi M, Kitada M. Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide. Molecular Pharmacology 1993; 44: 216–221
   PubMed Web of Science ®Google Scholar
• Nakazawa K, Tanaka H. Pharmacokinetics of caffeine and dimethylxanthines in plasma and saliva. Yakugaku Zasshi 1988; 108: 653–658, [in Japanese]
   PubMed Web of Science ®Google Scholar
• Nishida Y, Fukuda T, Yamamoto I, Azuma J. CYP2D6 genotypes in a Japanese population: Low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10. Pharmacogenetics 2000; 10: 567–570
   PubMedGoogle Scholar
• Noda T, Todani T, Watanabe Y, Yamamoto S. Liver volume in children measured by computed tomography. Pediatric Radiology 1997; 27: 250–252
   PubMed Web of Science ®Google Scholar
• Ogiu N, Nakamura Y, Ijiri I, Hiraiwa K, Ogiu T. A statistical analysis of the internal organ weights of normal Japanese people. Health Physics 1997; 72: 368–383
   PubMed Web of Science ®Google Scholar
• Otani K, Yasui N, Furukori H, Kaneko S, Tasaki H, Ohkubo T, Nagasaki T, Sugawara K, Hayashi K. Relationship between single oral dose pharmacokinetics of alprazolam and triazolam. International Clinical Psychopharmacology 1997a; 12: 153–157
   PubMed Web of Science ®Google Scholar
• Otani K, Yasui N, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Hayashi K, Chiba K, Ishizaki T. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam. Neuropsychopharmacology 1997b; 16: 8–14
   PubMed Web of Science ®Google Scholar
• Pfizer, Inc. Viagra tablets (Japanese). Prescribing Information. Pfizer, Inc. 2003
   Google Scholar
• Proctor NJ, Rostami-Hodjegan A, Tucker GT. In vitro prediction of population in vivo drug clearance using updatd scaling factors. British Journal of Clinical Pharmacology 2003; 55: 445
   Web of Science ®Google Scholar
• Rowland-Yeo K, Rostami-Hodjegan A, Tucker GT. Abundance of cytochromes P450 in human liver: A meta-analysis. British Journal of Clinical Pharmacology 2004; 57: 687
   Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics 1994; 270: 414–423
   PubMed Web of Science ®Google Scholar
• Shu Y, Cheng ZN, Liu ZQ, Wang LS, Zhu B, Huang SL, Ou-Yang DS, Zhou HH. Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects. Acta Pharmacologica Sinica 2001; 22: 283–288
   PubMed Web of Science ®Google Scholar
• Sohn DR, Shin SG, Park CW, Kusaka M, Chiba K, Ishizaki T. Metoprolol oxidation polymorphism in a Korean population: Comparison with native Japanese and Chinese populations. British Journal of Clinical Pharmacology 1991; 32: 504–507
   PubMed Web of Science ®Google Scholar
• Takahara S, Ohta K, Ohashi Y, Namii Y, Uchida K, Okuyama A, Kainuma H, Takagi H, Takahashi K, Morikawa H. Comparative pharmacokinetic study of neoral versus Sandimmun in Japanese stable renal allograft recipients. Transplantation Proceedings 2001; 33: 2541–2544
   PubMed Web of Science ®Google Scholar
• Takahashi H, Echizen H. Pharmacogenetics of warfarin elimination and its clinical implications. Clinical Pharmacokinetics 2001; 40: 587–603
   PubMed Web of Science ®Google Scholar
• Takahashi H, Ishikawa S, Nomoto S, Nishigaki Y, Ando F, Kashima T, Kimura S, Kanamori M, Echizen H. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children. Clinical Pharmacology and Therapeutics 2000; 68: 541–555
   PubMed Web of Science ®Google Scholar
• Takahashi H, Kashima T, Kimura S, Murata N, Takaba T, Iwade K, Abe T, Tainaka H, Yasumori T, Echizen H. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: Application of in vitro approaches to predicting In vivo reduction of (S)-warfarin clearance. Drug Metabolism and Disposition 1999b; 27: 1179–1186
   PubMed Web of Science ®Google Scholar
• Takahashi H, Sato T, Shimoyama Y, Shioda N, Shimizu T, Kubo S, Tamura N, Tainaka H, Yasumori T, Echizen H. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone. Clinical Pharmacology and Therapeutics 1999a; 66: 569–581
   PubMed Web of Science ®Google Scholar
• Takahashi H, Wilkinson GR, Caraco Y, Muszkat M, Kim RB, Kashima T, Kimura S, Echizen H. Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients. Clinical Pharmacology and Therapeutics 2003; 73: 253–263
   PubMed Web of Science ®Google Scholar
• Tanaka E, Ishikawa A, Yamamoto Y, Osada A, Tsuji K, Fukao K, Iwasaki Y. Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects. Pharmacology and Toxicology 1993; 72: 31–33
   PubMedGoogle Scholar
• Tanaka E, Ishikawa A, Yamamoto Y, Osada A, Tsuji K, Fukao K, Misawa S, Iwasaki Y. A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites. International Journal of Clinical Pharmacology and Therapeutics 1992; 30: 336–341
   Web of Science ®Google Scholar
• Tateishi T, Nakura H, Asoh M, Watanabe M, Tanaka M, Kumai T, Takashima S, Imaoka S, Funae Y, Yabusaki Y, et al. A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. Life Sciences 1997; 61: 2567–2574
   PubMed Web of Science ®Google Scholar
• Tateishi T, Watanabe M, Moriya H, Yamaguchi S, Sato T, Kobayashi S. No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins. Biochemical Pharmacology 1999; 57: 935–939
   PubMed Web of Science ®Google Scholar
• Tateishi T, Watanabe M, Nakura H, Asoh M, Shirai H, Mizorogi Y, Kobayashi S, Thummel KE, Wilkinson GR. CYP3A activity in European American and Japanese men using midazolam as an in vivo probe. Clinical Pharmacology and Therapeutics 2001; 69: 333–339
   PubMed Web of Science ®Google Scholar
• Thomsen MS, Chassard D, Evene E, Nielsen KK, Jorgensen M. Pharmacokinetics of repaglinide in healthy Caucasian and Japanese subjects. Journal of Clinical Pharmacology 2003; 43: 23–28
   PubMed Web of Science ®Google Scholar
• Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, Momose Y, Komiyama A, Makuuchi M. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995; 21: 1317–1321
   PubMed Web of Science ®Google Scholar
• Valetin J. Basic anatomical and physiological data for use in radiological protection: Reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. Annals of the ICRP, Publication 89 2002; 32: 5–265
   PubMedGoogle Scholar
• Van Gerven JM, Uchida E, Uchida N, Pieters MS, Meinders AJ, Schoemaker RC, Nanhekhan LV, Kroon JM, De Visser SJ, Altorf B, et al. Pharmacodynamics and pharmacokinetics of a single oral dose of nitrazepam in healthy volunteers: An interethnic comparative study between Japanese and European volunteers. Journal of Clinical Pharmacology 1998; 38: 1129–1136
   PubMed Web of Science ®Google Scholar
• Xie HG, Kim RB, Wood AJ, Stein CM. Molecular basis of ethnic differences in drug disposition and response. Annual Review of Pharmacology and Toxicology 2001; 41: 815–850
   PubMed Web of Science ®Google Scholar
• Yang JS, Rostami-Hodjegan A, Tucker GT. Prediction of ketoconazole interaction with midazolam, alprazolam and triazolam: Incorporating population variability. British Journal of Clinical Pharmacology 2001a; 52: 472–473
   Google Scholar
• Yang JS, Rostami-Hodjegan A, Tucker GT. Prediction of fluconazole interaction with midazolam and triazolam: Incorporating population variability. British Journal of Clinical Pharmacology 2001b; 52: 484
   Google Scholar
• Yang JS, Rostami-Hodjegan A, Tucker GT. Prediction of ritonavir interaction with sildenafil (Viagra): Incorporating population variability. British Journal of Clinical Pharmacology 2002; 53: 438–439
   Web of Science ®Google Scholar
• Yasui N, Kondo T, Furukori H, Kaneko S, Ohkubo T, Uno T, Osanai T, Sugawara K, Otani K. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam. Psychopharmacology (Berlin) 2000; 150: 185–190
   PubMed Web of Science ®Google Scholar
• Yasui N, Kondo T, Otani K, Furukori H, Kaneko S, Ohkubo T, Nagasaki T, Sugawara K. Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam. Psychopharmacology (Berlin) 1998; 139: 269–273
   PubMed Web of Science ®Google Scholar
• Yasui N, Otani K, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Chiba K, Ishizaki T. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: In vivo evidence for the involvement of CYP3A4 in alprazolam metabolism. Clinical Pharmacology and Therapeutics 1996; 59: 514–519
   PubMed Web of Science ®Google Scholar
• Yasui N, Otani K, Ohkubo T, Osanai T, Sugawara K, Chiba K, Ishizaki T, Kaneko S. Single-dose pharmacokinetics and pharmacodynamics of oral triazolam in relation to cytochrome P4502C19 (CYP2C19) activity. Therapeutic Drug Monitoring 1997; 19: 371–374
   PubMed Web of Science ®Google Scholar
• Yasui-Furukori N, Kondo T, Kubota T, Otake H, Ohkubo T, Nagasaki T, Sugawara K, Chiba K, Otani K, Kaneko S. No correlations between the urinary ratio of 6beta-hydroxycortisol to free cortisol and pharmacokinetics of alprazolam. European Journal of Clinical Pharmacology 2001; 57: 285–288
   PubMed Web of Science ®Google Scholar
• Yasumori T, Murayama N, Yamazoe Y, Kato R. Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2. Clinical Pharmacology and Therapeutics 1990; 47: 313–322
   PubMed Web of Science ®Google Scholar
• Yasumori T, Nagata K, Yang SK, Chen LS, Murayama N, Yamazoe Y, Kato R. Cytochrome P450 mediated metabolism of diazepam in human and rat: Involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 1993; 3: 291–301
   PubMedGoogle Scholar
• Yates RA, Tateno M, Nairn K, Ikegami A, Dane A, Kemp J. The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects. European Journal of Clinical Pharmacology 2002; 58: 247–252
   PubMed Web of Science ®Google Scholar
• Zhou Q, Yamamoto I, Fukuda T, Ohno M, Sumida A, Azuma J. CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin. European Journal of Clinical Pharmacology 1999; 55: 43–47
   PubMed Web of Science ®Google Scholar